King International Investment Ltd
00928
Company Profile
Business description
King International Investment Ltd is an investment holding company. The company's operating segment includes the Healthcare products and services business, Money lending business and sales of liquor business. It generates maximum revenue from the sales of liquor business segment. Geographically, it derives a majority of revenue from PRC. The group is a provider of genetic testing and health data analysis services.
Contact
No. 338 King’s Road
Suite 2001, 20th floor
Two Chinachem Exchange Square
North Point
Hong Kong
HKGSector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 March 2026
Employees
13
Stocks News & Analysis
stocks
Netflix: A business that’s nearly flawless
Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.
stocks
Trump’s US dollar assault is fuelling CBA’s rise
A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.
stocks
Insignia Financial: Revised deal still attractive
The offer price is well above our fair value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,979.40 | 22.00 | -0.24% |
| CAC 40 | 7,850.43 | 106.02 | 1.37% |
| DAX 40 | 24,240.82 | 198.92 | 0.83% |
| Dow JONES (US) | 45,010.29 | 507.85 | 1.14% |
| FTSE 100 | 9,061.49 | 37.68 | 0.42% |
| HKSE | 25,621.79 | 83.72 | 0.33% |
| NASDAQ | 21,020.02 | 127.33 | 0.61% |
| Nikkei 225 | 41,881.24 | 709.92 | 1.72% |
| NZX 50 Index | 12,805.13 | 11.07 | 0.09% |
| S&P 500 | 6,358.91 | 49.29 | 0.78% |
| S&P/ASX 200 | 8,709.60 | 27.60 | -0.32% |
| SSE Composite Index | 3,593.84 | 11.54 | 0.32% |